Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Recent Teva and Roche patents disclose new antipsychotic agents

Dec. 3, 2008

TorreyPines reports results from study of NGX-426 in capsaicin-induced pain

Dec. 2, 2008

Paladin and GSK sign 3-year distribution agreement for Dexedrine for ADHD

Dec. 2, 2008

Positive results reported for novel HDAC inhibitor in experimental Huntington's disease in mice

Dec. 2, 2008

Prana provides update on research and development programs

Dec. 2, 2008

Novel dual CB1/CB2 receptor agonist efficacious in experimental pain models

Dec. 2, 2008

Lilly withdraws Cymbalta sNDA, plans to resubmit in 2009 with additional data

Dec. 1, 2008

New sodium channel blocker shows potential in models of epilepsy and psychiatric disorders

Dec. 1, 2008

Antiparkinsonian and neuroprotective effects of novel MAO-B inhibitor

Dec. 1, 2008

S-24795, an alpha7 nAChR partial agonist, may be useful in Alzheimer's disease

Dec. 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...